These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26374327)

  • 1. Fosfomycin use in multi drug resistant uropathogenic Escherichia coli.
    Mittal S; Sharma M; Chaudhary U
    Infect Disord Drug Targets; 2015; 15(3):196-201. PubMed ID: 26374327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biofilm and multidrug resistance in uropathogenic Escherichia coli.
    Mittal S; Sharma M; Chaudhary U
    Pathog Glob Health; 2015 Feb; 109(1):26-9. PubMed ID: 25605466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
    Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
    Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
    Arredondo-García JL; Amábile-Cuevas CF
    J Infect Dev Ctries; 2008 Oct; 2(5):350-3. PubMed ID: 19745501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of virulence factors of uropathogenic Escherichia coli and its antibiotic susceptibility pattern.
    Mittal S; Sharma M; Chaudhary U
    Indian J Pathol Microbiol; 2014; 57(1):61-4. PubMed ID: 24739833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in North of Iran.
    Sheikhi R; Amini ME; Alidoust L; Atrkar Roushan Z; Nikokar I
    J Infect Dev Ctries; 2024 May; 18(5):761-769. PubMed ID: 38865401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-Vitro Biofilm Formation and Antimicrobial Resistance of
    Raya S; Belbase A; Dhakal L; Govinda Prajapati K; Baidya R; Kishor Bimali N
    Biomed Res Int; 2019; 2019():1474578. PubMed ID: 31641666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilm formation, antimicrobial susceptibility and virulence genes of Uropathogenic Escherichia coli isolated from clinical isolates in Uganda.
    Katongole P; Nalubega F; Florence NC; Asiimwe B; Andia I
    BMC Infect Dis; 2020 Jun; 20(1):453. PubMed ID: 32600258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of class 1 and class 2 integron gene cassettes in Escherichia coli strains isolated from urine cultures: a multicenter study].
    Çopur Çiçek A; Sandallı C; Budak EE; Yağmur G; Çizmeci Z; Ak S; Balcı PÖ; Şay Coşkun SU; Ay Altıntop Y; Fırat M; Sarı F; Çalışkan A; Yıldız N; Sancaktar M; Özgümüş OB
    Mikrobiyol Bul; 2016 Apr; 50(2):175-85. PubMed ID: 27175490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection.
    González MJ; Da Cunda P; Notejane M; Zunino P; Scavone P; Robino L
    Pathog Dis; 2019 Apr; 77(3):. PubMed ID: 31062019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli.
    Ibrahim AA; Mohammed RK
    Braz J Microbiol; 2024 Jun; 55(2):1091-1097. PubMed ID: 38367167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of antibiotic resistance patterns, and the correlation between biofilm formation with virulence factors in uropathogenic E. coli isolated from urinary tract infections.
    Zhao F; Yang H; Bi D; Khaledi A; Qiao M
    Microb Pathog; 2020 Jul; 144():104196. PubMed ID: 32283258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-Acquired Uropathogenic
    Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
    MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between antimicrobial resistance, biofilm formation, and virulence determinants in uropathogenic Escherichia coli from Egyptian hospital.
    Alshaikh SA; El-Banna T; Sonbol F; Farghali MH
    Ann Clin Microbiol Antimicrob; 2024 Feb; 23(1):20. PubMed ID: 38402146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST].
    Süzük S; Kaşkatepe B; Avcıküçük H; Aksaray S; Başustaoğlu A
    Mikrobiyol Bul; 2015 Oct; 49(4):494-501. PubMed ID: 26649407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of acute urinary tract infections caused by uropathogenic
    Pullanhi U; Khan S; Vinod V; Mohan K; Kumar A
    Ann Afr Med; 2019; 18(3):138-142. PubMed ID: 31417014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virulence factors of uropathogenic Escherichia coli (UPEC) and correlation with antimicrobial resistance.
    Shah C; Baral R; Bartaula B; Shrestha LB
    BMC Microbiol; 2019 Sep; 19(1):204. PubMed ID: 31477018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Epidemiology of Antimicrobial Resistance of Uropathogenic
    Neamati F; Khorshidi A; Moniri R; Hosseini Tafreshi SA
    Microb Drug Resist; 2020 Jan; 26(1):60-70. PubMed ID: 31526226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
    Harwalkar A; Gupta S; Rao A; Srinivasa H
    J Infect Public Health; 2014; 7(5):413-9. PubMed ID: 24861644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
    Rodríguez-Avial C; Rodríguez-Avial I; Hernández E; Picazo JJ
    Rev Esp Quimioter; 2013 Mar; 26(1):43-6. PubMed ID: 23546462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.